ExLibris header image
SFX Logo
Title: PARP3 affects the relative contribution of homologous recombination and nonhomologous end-joining pathways
Source:

Nucleic Acids Research [0305-1048] Beck, C yr:2014


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Castiglia, G. "Monozygotic twins discordant for recessive dystrophic epidermolysis bullosa phenotype highlight the role of TGF-β signalling in modifying disease severity." Human molecular genetics 23.15 (2014): 3907-3922. Link to SFX for this item
2. Getahun, D. "The impact of changes in preterm birth among twins on stillbirth and infant mortality in the United States." Journal of perinatology 34.11 (2014): 823-829. Link to Full Text for this item Link to SFX for this item
3. Fuhrmann, G. "Selective anticancer effects of a synthetic flavagline on human Oct4-expressing cancer stem-like cells via a p38 MAPK-dependent caspase-3-dependent pathway." Biochemical pharmacology (2014). Link to SFX for this item
4. McGrath, G A. "Fibroblast cell therapy enhances initial healing in recessive dystrophic epidermolysis bullosa wounds: results of a randomised, vehicle-controlled trial." British journal of dermatology 169.5 (2013): 1025-1033. Link to Full Text for this item Link to SFX for this item
5. Barrett, J F. "Maternal outcomes at 3 months after planned caesarean section versus planned vaginal birth for twin pregnancies in the Twin Birth Study: a randomised controlled trial." BJOG: an international journal of obstetrics and gynaecology 122.12 (2015): 1653-1662. Link to Full Text for this item Link to SFX for this item
6. Costello Harris, Vanessa A. "The unmet concerns of twins with special needs: diagnostic challenges and service recommendations." Community Practitioner 88.2 (2015): 32-5. Link to SFX for this item
7. Chang, Y. "Multidirectional effects of sr-, mg-, and si-containing bioceramic coatings with high bonding strength on inflammation, osteoclastogenesis, and osteogenesis." ACS applied materials & interfaces 6.6 (2014): 4264-4276. Link to Full Text for this item Link to SFX for this item
8. Hsu, C. "Treatment of Hereditary Epidermolysis Bullosa: Updates and Future Prospects." American journal of clinical dermatology 15.1 (2014): 1-6. Link to SFX for this item
9. Venugopal, S. "A phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa." Journal of the American Academy of Dermatology 69.6 (2013): 898-4294967295. Link to SFX for this item
10. Pope, E. "Epidermolysis Bullosa and Chronic Wounds: A Model for Wound Bed Preparation of Fragile Skin." Advances in Skin & Wound Care 26.4 (2013): 177-188. Link to SFX for this item
11. Morimoto, N. "Viability and function of autologous and allogeneic fibroblasts seeded in dermal substitutes after implantation." The Journal of surgical research 125.1 (2005): 56-67. Link to SFX for this item
12. Jellinek, Nathaniel J J. "The clinical influence of the JAAD." Journal of the American Academy of Dermatology 50.3 (2004): 470-4. Link to SFX for this item
13. Bang, Abhay T T. "Neonatal and infant mortality in the ten years (1993 to 2003) of the Gadchiroli field trial: effect of home-based neonatal care." Journal of perinatology 25.SUPPL. 1 (2005): -107. Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced